Bioprotect Secures $28M To Commercialize Its Biodegradable Balloon For Rectal Protection During Prostate Cancer Radiation Therapy
Amount Raised
$28 Million
Round Type
Funding Round
TZUR IGALManufacturingBiotechnologyHealth CareInvestors
Description
BioProtect Ltd, a private Med Tech company focused on providing innovative, biodegradable spacing solutions, announced today the successful close of a $28 million funding. The round was led by MVM Partners, with participation from current investors: Triventures, KB Investments, Peregrine Ventures, Almeda Ventures, and Consensus Business Group of Vincent Tchenguiz. Proceeds from this financing will support US commercialization of the BioProtect Balloon Implant System, which recently received FDA clearance for rectal protection during radiation therapy for prostate cancer.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as BioProtect that raised within 45 days of this round, from Fundz verified event records.
- SURGLASSES raised $6.5M (Funding Round) on November 9, 2023.
- Nature's Toolbox raised $44M on November 7, 2023.
- TendoNova raised $250K on November 1, 2023.
- Gyre Therapeutics raised $5M on October 30, 2023.
- Planatome raised $6M on October 25, 2023.
- VitaTek raised an undisclosed amount (Series A) on October 22, 2023.
Who to call at BioProtect, and when
A new round usually means BioProtect is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioProtect raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioProtect, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioProtect. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioProtect raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioProtect raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.